My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 171

    1.

    Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice.

    Suarez-Pinzon WL, Power RF, Yan Y, Wasserfall C, Atkinson M, Rabinovitch A.

    Diabetes. 2008 Dec;57(12):3281-8. Epub 2008 Oct 3.PMID: 18835930 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Combination therapy with glucagon-like peptide-1 and gastrin induces beta-cell neogenesis from pancreatic duct cells in human islets transplanted in immunodeficient diabetic mice.

    Suarez-Pinzon WL, Lakey JR, Rabinovitch A.

    Cell Transplant. 2008;17(6):631-40.PMID: 18819251 [PubMed - indexed for MEDLINE]Related articles

    3.

    Combination therapy with epidermal growth factor and gastrin increases beta-cell mass and reverses hyperglycemia in diabetic NOD mice.

    Suarez-Pinzon WL, Yan Y, Power R, Brand SJ, Rabinovitch A.

    Diabetes. 2005 Sep;54(9):2596-601.PMID: 16123347 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Combination therapy with epidermal growth factor and gastrin delays autoimmune diabetes recurrence in nonobese diabetic mice transplanted with syngeneic islets.

    Suarez-Pinzon WL, Rabinovitch A.

    Transplant Proc. 2008 Mar;40(2):529-32.PMID: 18374121 [PubMed - indexed for MEDLINE]Related articles

    5.

    Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.

    Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.

    Transplantation. 2009 Jan 27;87(2):198-206.PMID: 19155973 [PubMed - indexed for MEDLINE]Related articles

    6.

    Continuous stimulation of human glucagon-like peptide-1 (7-36) amide in a mouse model (NOD) delays onset of autoimmune type 1 diabetes.

    Zhang J, Tokui Y, Yamagata K, Kozawa J, Sayama K, Iwahashi H, Okita K, Miuchi M, Konya H, Hamaguchi T, Namba M, Shimomura I, Miyagawa JI.

    Diabetologia. 2007 Sep;50(9):1900-9. Epub 2007 Jul 14.PMID: 17632702 [PubMed - indexed for MEDLINE]Related articles

    7.

    Combination therapy with cyclosporine and interleukin-4 or interleukin-10 prolongs survival of synergeneic pancreatic islet grafts in nonobese diabetic mice: islet graft survival does not correlate with mRNA levels of type 1 or type 2 cytokines, or transforming growth factor-beta in the islet grafts.

    Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Rajotte RV, Power RF.

    Transplantation. 1997 Dec 15;64(11):1525-31.PMID: 9415551 [PubMed - indexed for MEDLINE]Related articles

    8.

    Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57Bl6/J mice treated with alloxan.

    Rooman I, Bouwens L.

    Diabetologia. 2004 Feb;47(2):259-65. Epub 2003 Dec 10.PMID: 14666367 [PubMed - indexed for MEDLINE]Related articles

    9.

    Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.

    Reddy S, Cheung CC, Chai RC, Rodrigues JA.

    Ann N Y Acad Sci. 2008 Dec;1150:171-6.PMID: 19120289 [PubMed - indexed for MEDLINE]Related articles

    10.

    Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.

    Green BD, Lavery KS, Irwin N, O'harte FP, Harriott P, Greer B, Bailey CJ, Flatt PR.

    J Pharmacol Exp Ther. 2006 Aug;318(2):914-21. Epub 2006 Apr 28.PMID: 16648370 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Prolonged remission of diabetes by regeneration of beta cells in diabetic mice treated with recombinant adenoviral vector expressing glucagon-like peptide-1.

    Liu MJ, Shin S, Li N, Shigihara T, Lee YS, Yoon JW, Jun HS.

    Mol Ther. 2007 Jan;15(1):86-93.PMID: 17164779 [PubMed - indexed for MEDLINE]Related articles

    12.

    Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.

    Hancock WW, Polanski M, Zhang J, Blogg N, Weiner HL.

    Am J Pathol. 1995 Nov;147(5):1193-9.PMID: 7485382 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Pharmacological treatment of chronic diabetes by stimulating pancreatic beta-cell regeneration with systemic co-administration of EGF and gastrin.

    Brand SJ, Tagerud S, Lambert P, Magil SG, Tatarkiewicz K, Doiron K, Yan Y.

    Pharmacol Toxicol. 2002 Dec;91(6):414-20. Review.PMID: 12688387 [PubMed - indexed for MEDLINE]Related articles

    14.

    Glucagon-like-peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice.

    Linn T, Schneider K, Göke B, Federlin K.

    Acta Diabetol. 1996 Mar;33(1):19-24.PMID: 8777280 [PubMed - indexed for MEDLINE]Related articles

    15.

    Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.

    Shapiro AM, Suarez-Pinzon WL, Power R, Rabinovitch A.

    Diabetologia. 2002 Feb;45(2):224-30.PMID: 11935154 [PubMed - indexed for MEDLINE]Related articles

    16.

    Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.

    Farilla L, Hui H, Bertolotto C, Kang E, Bulotta A, Di Mario U, Perfetti R.

    Endocrinology. 2002 Nov;143(11):4397-408.PMID: 12399437 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice.

    Rabinovitch A, Suarez-Pinzon WL, Shapiro AM, Rajotte RV, Power R.

    Diabetes. 2002 Mar;51(3):638-45.PMID: 11872661 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.

    Bergerot I, Fabien N, Thivolet C.

    Diabetes Metab. 1996 Jul;22(4):235-9.PMID: 8767168 [PubMed - indexed for MEDLINE]Related articles

    19.

    Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice.

    Luo X, Yang H, Kim IS, Saint-Hilaire F, Thomas DA, De BP, Ozkaynak E, Muthukumar T, Hancock WW, Crystal RG, Suthanthiran M.

    Transplantation. 2005 May 15;79(9):1091-6.PMID: 15880049 [PubMed - indexed for MEDLINE]Related articles

    20.

    Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice. Analysis of cytokine mRNA expression in the graft.

    Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF, Rajotte RV.

    Transplantation. 1995 Aug 27;60(4):368-74.PMID: 7652767 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity